Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 16Completed 12Unknown 9Active not recruiting 5Terminated 2Withdrawn 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 5NIH 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Endocrine 5Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 630Prostatic Neoplasms 372Neoplasms 305Carcinoma, Non-Small-Cell Lung 215Lung Neoplasms 204Colorectal Neoplasms 176Multiple Myeloma 143Pancreatic Neoplasms 136Leukemia, Myeloid, Acute 128Neoplasm Metastasis 124Brain Neoplasms 117Melanoma 116Ovarian Neoplasms 101Carcinoma, Hepatocellular 101Precursor Cell Lymphoblastic Leukemia-Lymphoma 100Glioblastoma 99Uterine Cervical Neoplasms 97Head and Neck Neoplasms 94Squamous Cell Carcinoma of Head and Neck 93Colonic Neoplasms 82Stomach Neoplasms 80Recurrence 80Rectal Neoplasms 80Urinary Bladder Neoplasms 77Sarcoma 77Carcinoma, Renal Cell 76Triple Negative Breast Neoplasms 75Lymphoma 71Lymphoma, Non-Hodgkin 67Leukemia, Lymphocytic, Chronic, B-Cell 66

Interventions

sodium thiosulfate 1pembrolizumab 1Nivolumab 1Ipilimumab 1Cytoreduction Surgical Procedures 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Adrenocortical Carcinoma × Clear all
NCT00457587 2026-05-07

Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma

University of Wuerzburg

Active not recruiting
150 enrolled
Endocrine

Cushing Syndrome, Adrenocortical Carcinoma

NCT00568139 2026-05-07

Evaluation of Side Effects of Mitotane

University of Wuerzburg

Active not recruiting
400 enrolled
Endocrine

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT03127774 2026-05-06

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Columbia University

Phase 2 Active not recruiting
30 enrolled
EndocrineGynecologic

Peritoneal Neoplasms, Adrenocortical Carcinoma

NCT02673333 2026-04-06

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
39 enrolled 7 charts
Endocrine

Adrenocortical Carcinoma

NCT03333616 2026-01-21

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
100 enrolled
EndocrineGenitourinary

Penile Neoplasms, Urogenital Neoplasms, Adrenocortical Carcinoma, Carcinoma, Small Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡